Log in

460 Sihuan Pharmaceutical Holdings Group Ltd. HKEX · China

Sihuan Pharmaceutical Holdings Group (460) news

Sihuan Pharmaceutical Holdings Group Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 460, recorded under China. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Sihuan Pharmaceutical Holdings Group news

We have not published a story on Sihuan Pharmaceutical Holdings Group yet. When there is news, it will appear here.

Questions about Sihuan Pharmaceutical Holdings Group

What is the ticker symbol of Sihuan Pharmaceutical Holdings Group?

Sihuan Pharmaceutical Holdings Group Ltd. trades under the ticker 460 on HKEX.

Where is Sihuan Pharmaceutical Holdings Group listed?

Sihuan Pharmaceutical Holdings Group Ltd. is listed on HKEX.

Which country or territory is Sihuan Pharmaceutical Holdings Group listed under?

Our directory records Sihuan Pharmaceutical Holdings Group Ltd. under China.

What does Sihuan Pharmaceutical Holdings Group do?

Our directory classifies Sihuan Pharmaceutical Holdings Group Ltd. as: Biopharma / pharmaceutical profile checked. This is a directory classification, not a description of the pipeline.

What is the ISIN of Sihuan Pharmaceutical Holdings Group?

The ISIN recorded for Sihuan Pharmaceutical Holdings Group Ltd. is BMG8162K1137.

Does aibio.space cover Sihuan Pharmaceutical Holdings Group?

aibio.space lists Sihuan Pharmaceutical Holdings Group Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Sihuan Pharmaceutical Holdings Group?

Companies in our directory listed in the same country and business area as Sihuan Pharmaceutical Holdings Group: Lionco Pharmaceutical Group Co., China Resources Jiangzhong Pharmaceutical Co., Shanxi Zhendong Pharmaceutical Co., Shanghai Kaibao Pharmaceutical Co., Lanzhou Foci Pharmaceutical Co., NOVAST LABORATORIES LTD.

Investor discussion: Sihuan Pharmaceutical Holdings Group

Members talk about Sihuan Pharmaceutical Holdings Group (460). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Sihuan Pharmaceutical Holdings Group, newest first. Each line links the filing it comes from.

  1. Financings

    Share or debt issue: PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, DECLARATION AND PAYMENT OF A FINAL CASH DIVIDEND, RE-ELECTION OF RETIRING DIRECTORS, RE-APPOINTMENT OF AUDITOR, PROPOSED ADOPTION OF THE 2026 SHARE INCENTIVE SCHEME AND NOTICE OF ANNUAL GENERAL MEETING. Source

  2. Financings

    Share or debt issue: PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING. Source

  3. Mergers

    Transaction under the Listing Rules: SUPPLEMENTAL ANNOUNCEMENT DISCLOSEABLE TRANSACTIONS AND CONNECTED TRANSACTIONS TRANSFER OF SHARES IN XUANZHU BIOPHARM. Source

  4. Mergers

    Transaction under the Listing Rules: PROPOSED SPIN-OFF AND SEPARATE LISTING OF XUANZHU BIOPHARM ON THE MAIN BOARD OF THE STOCK EXCHANGE; DISCLOSEABLE TRANSACTIONS AND CONNECTED TRANSACTIONS - TRANSFER OF SHARES IN XUANZHU BIOPHARM. Source

  5. Mergers

    Transaction under the Listing Rules: (1) VOLUNTARY ANNOUNCEMENT-PROPOSED SPIN-OFF OF XUANZHU BIOPHARM AND LISTING ON THE MAIN BOARD OF THE STOCK EXCHANGE AND (2) DISCLOSEABLE TRANSACTION-FURTHER ACQUISITION OF APPROXIMATELY 3.6177% EQUITY INTERESTS IN XUANZHU BIOPHARM. Source

Press releases

Headlines of Sihuan Pharmaceutical Holdings Group's own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. HKEXnews

    VOLUNTARY ANNOUNCEMENT- PHASE III CLINICAL STUDY DATA OF XUANZHU BIOPHARM'S ANAPRAZOLE SODIUM FOR REFLUX ESOPHAGITIS PRESENTED AT UEG WEEK 2026

  2. HKEXnews

    VOLUNTARY ANNOUNCEMENT - POLYCAPROLACTONE MICROSPHERE FACIAL FILLER FOR INJECTION AND HYALURONIC ACID SODIUM COMPOSITE SOLUTION FOR INJECTION INDEPENDENTLY DEVELOPED BY MEIYAN SPACE, A SUBSIDIARY OF SIHUAN PHARMACEUTICAL, APPROVED FOR MARKET LAUNCH IN HONG KONG

  3. HKEXnews

    VOLUNTARY ANNOUNCEMENT-SIHUAN PHARMACEUTICAL COMPLETED A STRATEGIC INVESTMENT IN CANTON BIOLOGICS TO ENHANCE THE LAYOUT OF THE ENTIRE INDUSTRIAL CHAIN OF REGENERATIVE MEDICAL AESTHETICS

  4. HKEXnews

    VOLUNTARY ANNOUNCEMENT - NEW SPECIFICATIONS OF SKIN BOOSTER (BRAND NAME: DONGYAN) OF SIHUAN PHARMACEUTICAL APPROVED FOR LAUNCH BY NMPA

  5. HKEXnews

    Notification Letter and Request Form to Non-registered Holder

  6. HKEXnews

    Notification Letter and Change Request Form to Registered Shareholder

  7. HKEXnews

    VOLUNTARY ANNOUNCEMENT - XUANZHU BIOPHARM AND INNOBIC REACHED A COMMERCIAL COOPERATION FOR BIREOCICLIB IN THE THAILAND MARKET

  8. HKEXnews

    GRANT OF SHARE AWARDS

  9. HKEXnews

    VOLUNTARY ANNOUNCEMENT SHARE REPURCHASE

  10. HKEXnews

    ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2026

  11. HKEXnews

    RESIGNATION OF EXECUTIVE DIRECTOR, DEPUTY CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER APPOINTMENT OF NON-EXECUTIVE DIRECTOR AND APPOINTMENT OF CHIEF FINANCIAL OFFICER

  12. HKEXnews

    POSITIVE PROFIT ALERT

  13. HKEXnews

    VOLUNTARY ANNOUNCEMENT- NDA ACCEPTED BY NMPA FOR THE NEW INDICATION OF XUANZHU BIOPHARM'S ANAPRAZOLE SODIUM FOR THE TREATMENT OF REFLUX ESOPHAGITIS

  14. HKEXnews

    POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 26 JUNE 2026

  15. HKEXnews

    VOLUNTARY ANNOUNCEMENT- FIRST PATIENT ENROLLED IN PHASE III CLINICAL TRIAL OF XUANZHU BIOPHARM'S ANAPRAZOLE SODIUM FOR THE NEW INDICATION OF HELICOBACTER PYLORI ERADICATION

  16. HKEXnews

    An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

  17. HKEXnews

    VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO THE SHARE AWARD SCHEME

  18. HKEXnews

    NOTICE OF ANNUAL GENERAL MEETING

  19. HKEXnews

    PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, DECLARATION AND PAYMENT OF A FINAL CASH DIVIDEND, RE-ELECTION OF RETIRING DIRECTORS, RE-APPOINTMENT OF AUDITOR, PROPOSED ADOPTION OF THE 2026 SHARE INCENTIVE SCHEME AND NOTICE OF ANNUAL GENERAL MEETING

  20. HKEXnews

    VOLUNTARY ANNOUNCEMENT- SIHUAN PHARMACEUTICAL SIGNS COOPERATION AGREEMENT WITH DPROTEIN TO DEEPEN STRATEGIC LAYOUT OF AI IN THE FULL INDUSTRIAL CHAIN OF MEDICAL AESTHETICS AND INNOVATIVE DRUGS

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:460 on TradingView.

Listing details

Sihuan Pharmaceutical Holdings Group Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 460, recorded under China. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Sihuan Pharmaceutical Holdings Group Ltd.
Ticker
460
Listing
HKEX
Country or territory
China
Business scope
Biopharma / pharmaceutical profile checked
ISIN
BMG8162K1137
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.